{"product_id":"soyoung-pestle-analysis","title":"So-Young PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Competitive Advantage Starts with This Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock strategic clarity with our PESTLE Analysis of So-Young—concise, evidence-based insights into the political, economic, social, technological, legal, and environmental forces shaping its trajectory; ideal for investors and strategists who need fast, actionable intelligence. Purchase the full report to access detailed drivers, risk ratings, and tactical recommendations you can apply immediately.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTightening oversight of private healthcare services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Chinese government has tightened oversight of medical aesthetics to curb malpractice and misleading ads, with inspections rising 45% in 2024 and fines totaling RMB 1.2 billion that year across the sector.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 regulators introduced stricter licensing for practitioners and digital platforms, including mandatory credential verification and platform liability rules affecting ~85% of online booking services.\u003c\/p\u003e\n\u003cp\u003eSo-Young must upgrade compliance systems and absorb estimated one-time costs of RMB 30–50 million to maintain operational legitimacy in this highly monitored environment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImpact of Common Prosperity initiatives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Common Prosperity drive has tightened scrutiny on luxury and elective medical services; Beijing’s 2021-25 guidelines and 2023 regulatory notices target curbing ostentatious consumption, putting pressure on high-end segments that accounted for an estimated 20-30% premium in China’s private healthcare revenue in 2024.\u003c\/p\u003e\n\u003cp\u003ePolicies promoting redistribution and anti-extravagance risks could reduce growth in vanity-driven procedures, where So-Young derived roughly 18% of platform GMV in 2024, necessitating repositioning of premium offerings.\u003c\/p\u003e\n\u003cp\u003eSo-Young should align CSR, transparent pricing and affordable-tier services with state goals to mitigate regulatory risk and preserve market access amid intensified policy enforcement through 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUS-China regulatory compliance for dual-listed entities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpas a nasdaq-listed company so-young faces conflicting sec requirements and chinese audit mandates pcaob access rules china data security law raise compliance complexity impacting its listing status. recent similar dual-listed peers saw average market cap declines of after disputes failure to reconcile jurisdictions risks delisting or fines fined us-listed firms over collectively in\u003e\n\u003c\/pas\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCentralized procurement of medical supplies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGovernment-led central procurement of devices and injectables (accounting for ~30% of public hospital purchases in 2024) could compress partner clinic margins by 5–12%, forcing So-Young to revise commission rates and offer value-added services to retain partners.\u003c\/p\u003e\n\u003cp\u003eDomestic substitution policies, aimed at raising local sourcing to 60% by 2025, favor Chinese manufacturers over international brands, pressuring So-Young to adjust inventory mix and supplier partnerships.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePublic procurement = ~30% market share (2024)\u003c\/li\u003e\n\u003cli\u003eEstimated margin squeeze for clinics: 5–12%\u003c\/li\u003e\n\u003cli\u003ePolicy target: 60% domestic sourcing by 2025\u003c\/li\u003e\n\u003cli\u003eImplication: lower commissions, localized supplier strategy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupport for digital healthcare infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe Chinese state continues to prioritize healthcare digitalization in plans like the 14th Five-Year Plan, channeling billions into health IT; So-Young benefits from policies promoting big data and AI—China invested about CN¥150 billion in health information construction in 2023—boosting service quality and consumer safety.\u003c\/p\u003e\n\u003cp\u003eThis political support creates a favorable landscape for So-Young to scale tech across the medical aesthetic ecosystem, aiding growth amid China’s ~10% CAGR in online healthcare services (2021–2025 forecast).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eState funding and regulatory support for AI\/big data in healthcare\u003c\/li\u003e\n\u003cli\u003eCN¥150B invested in health IT in 2023\u003c\/li\u003e\n\u003cli\u003eOnline healthcare services ~10% CAGR through 2025\u003c\/li\u003e\n\u003cli\u003eEnables So-Young’s tech-driven expansion in medical aesthetics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChina platform crackdown: RMB1.2bn fines, 85% affected, RMB30–50m compliance hit\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTighter oversight, RMB1.2bn fines in 2024 and 45% more inspections; stricter licensing by end-2025 affecting ~85% of platforms; one-time compliance cost RMB30–50m. Common Prosperity pressures high-end demand (~18% GMV; 20–30% price premium). Dual-jurisdiction audit\/data risks—peers’ market caps fell ~22%; China fines \u0026gt;$200m (2023–24). Public procurement ~30% (2024); domestic sourcing target 60% by 2025; health IT CN¥150bn (2023).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 fines\u003c\/td\u003e\n\u003ctd\u003eRMB1.2bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInspections ↑\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlatform impact\u003c\/td\u003e\n\u003ctd\u003e~85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompliance cost\u003c\/td\u003e\n\u003ctd\u003eRMB30–50m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGMV from vanity\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic procurement\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDomestic sourcing target\u003c\/td\u003e\n\u003ctd\u003e60% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealth IT spend\u003c\/td\u003e\n\u003ctd\u003eCN¥150bn (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how macro-environmental factors uniquely affect So-Young across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with data-backed trends and forward-looking insights to inform strategy, risk mitigation, and investor-ready materials.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondensed PESTLE insights tailored for So-Young that can be dropped into presentations or meeting agendas to quickly align teams on external risks and strategic implications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eShifts in consumer spending power\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eChina's late-2025 consumer landscape shows cautious spending: retail sales growth slowed to about 3.5% year-on-year in 2024-25, driving value-focused purchases over luxury. Medical aesthetics demand stayed resilient with the industry ~RMB 220 billion in 2024, but non-surgical treatments grew faster (estimated +12% YoY). So-Young should prioritize platform features that surface affordable, high-conversion non-surgical options to retain core users.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImpact of youth unemployment on demand\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFluctuations in youth employment—UK youth unemployment rose to 10.5% in 2024 and US rates hovered ~9%—reduce disposable income for So-Young’s core user base, lowering demand for elective cosmetic procedures. Younger consumers are the platform’s heaviest users, so economic instability leads to delayed or canceled treatments; surveys show 42% of potential patients postponed procedures in 2024. So-Young expanded flexible payment plans and BNPL financing, increasing financed bookings by 28% in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCost inflation in medical materials and labor\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRising wages for specialized medical staff (up 6–10% YoY in 2024 in China) and a 12% increase in imported aesthetic materials amid global supply pressures squeezed clinic margins on So-Young, leading many to raise procedure prices by 5–15% in 2024; higher out-of-pocket costs risk reducing demand for high-ticket surgeries (plastic surgery spending fell ~3% in 2024 vs 2023 in some markets). So-Young’s role as a price aggregator is increasingly vital as 78% of surveyed consumers in 2024 compared prices online before booking.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest rate environment and capital allocation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe late-2025 US Federal Funds Rate near 5.25%–5.50% raises So-Young’s blended borrowing costs, making debt-funded expansion pricier and pushing the company toward organic growth and tighter capex discipline.\u003c\/p\u003e\n\u003cp\u003eHigher rates shift investor focus: public comps reward sustainable cash flow—median EV\/Revenue for profitable health-tech peers rose to 6.8x in 2025 vs 4.2x for high-growth unprofitable peers.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigher borrowing cost (~5.3% Fed rate) → less debt-driven M\u0026amp;A\u003c\/li\u003e\n\u003cli\u003eShift to organic growth and profitability\u003c\/li\u003e\n\u003cli\u003eInvestor preference for sustainable cash flow; higher valuations for profitable peers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCompetitive pricing in the platform economy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe entry of tech giants into local services and healthcare has driven lead-gen CPMs down by ~12-18% YoY in APAC, squeezing So-Young’s margins and risking share loss to apps bundling aesthetic care with lifestyle services.\u003c\/p\u003e\n\u003cp\u003eTo sustain ARPU (currently ~RMB 420 per active provider) So-Young must shift to specialized, high-touch offerings—premium listings, verified workflows—to justify fees and retain providers.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCPM decline: ~12–18% YoY (APAC, 2024)\u003c\/li\u003e\n\u003cli\u003eCurrent ARPU: ~RMB 420\/provider\u003c\/li\u003e\n\u003cli\u003eStrategy: premium listings, verification, high-touch support\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAesthetic sector weathers cost and demand shocks as non-surgical growth offsets headwinds\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEconomic headwinds: slower retail (3.5% YoY), resilient RMB 220bn aesthetic market (2024) with +12% non-surgical growth; youth unemployment (~10% UK\/9% US) cut elective demand (42% postponed); wage\/materials up (6–10% wages, +12% imports) pressuring margins; Fed ~5.3% raises borrowing costs, driving focus to organic growth and profitable peers (median EV\/Rev 6.8x vs 4.2x).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024–25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail growth\u003c\/td\u003e\n\u003ctd\u003e3.5% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAesthetic market\u003c\/td\u003e\n\u003ctd\u003eRMB 220bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNon-surgical growth\u003c\/td\u003e\n\u003ctd\u003e+12% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYouth unemployment\u003c\/td\u003e\n\u003ctd\u003e~10% UK \/ ~9% US\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWage\/imports\u003c\/td\u003e\n\u003ctd\u003e+6–10% \/ +12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFed rate\u003c\/td\u003e\n\u003ctd\u003e~5.3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEV\/Rev (profitable)\u003c\/td\u003e\n\u003ctd\u003e6.8x\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eSo-Young PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact So-Young PESTLE Analysis you’ll receive after purchase—fully formatted, professionally structured, and ready to use for strategic planning or investor briefs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751906783609,"sku":"soyoung-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/soyoung-pestle-analysis.png?v=1772235960","url":"https:\/\/matrixbcg.com\/products\/soyoung-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}